Acomplia Rimonabant diet pill is one of the best and well know diet pill nowadays. This pill is made by a french drug maker called Sanofi-Synthelabo. This drug maker developed Rimonabant Acomplia and this drug became maybe the best weight loss formula. Its main action is to block the CB1 receptors and you have to know that it’s doing its job very well.
Acomplia Rimonabant diet pills is maybe the most popular diet pill of all. Therefore it is very important for people to know how it works. Actually you must know exactly how Acomplia works in your body. For the beginning we tell you that Acomplia Rimonabant is the very first CB1 cannabinoid receptor blocker. These CB1 receptors are found in our brains and they are the direct link to hunger and smoking urge. So with Rimonabant Acomplia you have the possibility to solve two big problems: losing weight and stop smoking. By blocking those CB1 receptors Acomplia will cut off your need of extra food. In this way you will start losing weight immediately and also you will be able to have your weight under control.
Rimonabant Acomplia offers you great results if you take it as you should and as you are told to. But you must know that these results will be even grater if you help Acomplia tablets or diet pills with some exercises and a healthy good diet. Now you have the opportunity to achieve the weight you ever dreamed to and all you have to do is give a few clicks. Buy now Rimonabant Acomplia Online and you will be able to achieve the weight you ever dreamed of quickly and easily than you can imagine.
Now you have in Acomplia one of the best ally against obesity and extra weight you can have. Now you have the possibility to enjoy your life and to stay away from extra weight and smoking too. Buy Acomplia online and you will feel great and free. Your life will be better than ever before.
People that use Acomplia Rimonabant must be more carreful and pay attention to a problem that producer Sanofi-Aventis is now facing : If people don’t want to gain back the weight they lost on Acomplia, people are obligated to take this medication every day for the rest of their life.
In the Phase III clinical trials for Acomplia Rimonabant, people who were on rimonabant for a year lost up to 10 percent of their body weight. But while those who continued on Acomplia for a second year maintained their weight loss, those switched to a placebo tended to quickly regain the weight.
That could only suggest that if you want to keep weight lost while taking Acomplia Rimonabant from returning, people must take rimonabant indefinitely — a point the FDA advisory panel picked up on in majority and in conclusion that not enough long-term safety data had been submitted by producer Sanofi.
The FDA advisory panel declared in the minutes of the reunion that :”There was general agreement among the committee that there needs to be more long-term data; the concern being that of having limited 2-year study data being used to assess a medication that is going to be used for a longterm,”
Cluzel said “With any kind of chronic disease, when you stop the treatment — in fact, whether you are taking an antihypertensive medication, when you abandon the treatment you gain a really high blood pressure,and we think that it’s the case of Acomplia Rimonabant”
Cluzel,also said on the advisory panel statement “My opinion is that the review committee took recognizance at this moment that obesity is a chronic disease, and I think that is the spirit of the comment’’.